×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Decibel Therapeutics Inc. (DBTX) NASDAQ

$4.91 - (-)

Market Cap: -

As of 09/22/23 12:00 AM EDT. Market closed.

(DBTX)

Decibel Therapeutics Inc. (DBTX)
NASDAQ

$4.91
- (-)

Market Cap: -

As of 09/22/23 12:00 AM EDT. Market closed.

COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
Full Time Employees
85
URL
Address
.
PRICE CHART FOR DECIBEL THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.04
Previous Close
$4.91
Days Range
$4.90 - $5.11
52 week range
- - -
Volume
1,261,176
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
25,126,935
Open
$5.04
Previous Close
$4.91
Days Range
$4.90 - $5.11
52 week range
- - -
Volume
1,261,176
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
25,126,935
FINANCIAL STATEMENTS FOR DECIBEL THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR DECIBEL THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Trask AnnaSee RemarksDec 02, 2021 Sale$6.375,29133,6882,620Dec 06, 2021, 04:20 PM
Trask AnnaSee RemarksNov 03, 2021 Sale$8.343783,1527,533Nov 04, 2021, 08:00 AM
Trask AnnaSEE REMARKSNov 02, 2021 Sale$8.314,91340,8277,911Nov 03, 2021, 04:16 PM
Trask AnnaSee RemarksOct 14, 2021 Sale$7.555,36440,48112,824Oct 15, 2021, 04:57 PM
Reid LaurencePresident and Chief ExecutiveSep 15, 2021 Buy$7.6410,00076,40025,849Sep 17, 2021, 09:48 PM
ORBIMED ADVISORS LLCDirectorFeb 17, 2021 Buy$18.001,666,66629,999,9883,843,206Feb 19, 2021, 07:09 PM
Foy MatthewDirectorFeb 17, 2021 Buy$18.00150,0002,700,0001,183,663Feb 19, 2021, 06:59 PM
Casdin Partners Master Fund, L.P.10% OwnerFeb 17, 2021 Buy$18.00575,00010,350,0001,121,421Feb 19, 2021, 06:56 PM
Thompson Peter A.DirectorFeb 17, 2021 Buy$18.001,666,66629,999,9883,843,206Feb 19, 2021, 06:50 PM
GLAXOSMITHKLINE PLCDirectorFeb 17, 2021 Buy$18.00150,0002,700,0001,183,663Feb 19, 2021, 04:50 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Trask AnnaSee Remarks12/02/202133,688
Trask AnnaSee Remarks11/03/20213,152
Trask AnnaSEE REMARKS11/02/202140,827
Trask AnnaSee Remarks10/14/202140,481
Reid LaurencePresident and Chief Executive09/15/202176,400
ORBIMED ADVISORS LLCDirector02/17/202129,999,988
Foy MatthewDirector02/17/20212,700,000
Casdin Partners Master Fund, L.P.10% Owner02/17/202110,350,000
Thompson Peter A.Director02/17/202129,999,988
GLAXOSMITHKLINE PLCDirector02/17/20212,700,000
Load More Insider Transactions
FUNDS WITH A POSITION IN DECIBEL THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC4,945,1920.34%No changeOther
BLACKROCK INC.1,811,4830.00019%0.3%Other
UBS OCONNOR LLC199,2000.03%5.18%Value
GEODE CAPITAL MANAGEMENT, LLC115,5670.00005%No changeOther
RENAISSANCE TECHNOLOGIES LLC34,4000.00019%5.85%Other
CHANGE IN SHARES OUTSTANDING FOR DECIBEL THERAPEUTICS INC
STOCK BUYBACKS FOR DECIBEL THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
0.11%
1Q
06/30/2023
12/31/2022
0.21%
2Q
06/30/2023
09/30/2022
0.22%
3Q
06/30/2023
06/30/2022
0.24%
4Q
06/30/2023
03/31/2022
0.25%
5Q
06/30/2023
12/31/2021
0.27%
6Q
06/30/2023
09/30/2021
0.58%
7Q
06/30/2023
06/30/2021
0.61%
8Q
Load More

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
0.11%
1Q
12/31/2022
0.21%
2Q
09/30/2022
0.22%
3Q
06/30/2022
0.24%
4Q
03/31/2022
0.25%
5Q
12/31/2021
0.27%
6Q
09/30/2021
0.58%
7Q
06/30/2021
0.61%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR DECIBEL THERAPEUTICS INC
LOADING...